Apr 17, 09:07
67% of moneycontrol users recommend buying Piramal Enter. What's your call on Piramal Enter today? Read 32 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2548.40||0.36||2939.80||1904.15||43,350.54|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Piramal Enter is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 10,314.96 crore.The company has reported a consolidated sales of Rs 1,269.34 crore and a Net Loss of Rs 10.09 crore for the quarter ended Dec 2013.
The company management includes Ajay G Piramal - Chairman, Swati A Piramal - Vice Chairman, Nandini Piramal - Executive Director, Vijay Shah - COO & Executive Director, Gautam Banerjee - Non Executive Director, Amit Chandra - Director, Keki Dadiseth - Director, R A Mashelkar - Director, Goverdhan Mehta - Director, Siddharth Mehta - Ind.& Non Exe.Director, S Ramadorai - Director, Deepak Satwalekar - Director, N Vaghul - Director.
It is listed on the BSE with a BSE Code of 500302 and the NSE with an NSE Code of PEL.
Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel Mumbai,Maharashtra - 400013.
Their Registrars are Link Intime India Pvt. Ltd.